查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1446908

环糊精市场：按类型、最终用户产业：2023-2032 年全球机会分析与产业预测

Cyclodextrin Market By Type (Alpha-Cyclodextrin, Beta-Cyclodextrin, Gamma-Cyclodextrin), By End-User Industry (Food, Pharmaceutical, Cosmetics and Personal Care, Chemical, Textile, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 354 Pages | 商品交期: 2-3个工作天内

价格

2022年全球环糊精市场价值为3.34亿美元，预计到2032年将达到5.796亿美元，2023年至2032年的复合年增长率为5.7%。

环糊精市场-IMG1

环糊精是由α-1,4-糖苷键连接的葡萄糖单元所组成的环状寡糖。这些分子具有独特的圆环或截锥结构，其特征是疏水性中心空腔和亲水性外表面。环糊精以其与其他分子形成包合物的能力而闻名，从而使客体分子被封装在其中心空腔内。这项特性使环糊精可用于提高各种行业（如药品、食品和化妆品）中各种化合物的溶解度、稳定性和生物利用度等应用。

对永续性和绿色化学实践的日益重视也推动了环糊精市场的发展。环糊精可生物分解性且对环境友好，这使其对于优先考虑环保替代品的应用具有吸引力。使用环糊精代替传统化学品符合世界对永续实践的推动，并吸引了寻求环保解决方案的行业。

此外，各行业正在进行的研究和开发也有助于环糊精市场的扩大。研究人员正在探索利用环糊精独特性质的新应用和配方。这包括新型药物输送系统、改进的封装技术以及在农业和纺织等领域的创新应用。新应用的不断发现和独特配方的开发正在推动对环糊精的需求。

然而，监管的考量也正在影响环糊精市场。环糊精用于多种应用，包括药品和食品，因此遵守严格的监管要求至关重要。获得含环糊精产品的监管核准既耗时又昂贵。此外，不断变化的监管环境和合规标准可能需要製造商不断适应，从而增加市场的复杂性。

另一方面，在食品和饮料领域，环糊精被用作包封剂、风味改进剂和稳定剂。环糊精有助于提高产品品质、口味和保存期限。随着消费者越来越寻求更健康、更天然的成分，环糊精遮罩不良味道和气味的能力使其对食品製造商有价值。洁净标示产品的趋势和机能性食品的需求进一步推动了该细分市场的机会。

环糊精市场按类型、最终用户行业和地区细分。依类型划分，市场分为α-环糊精、β-环糊精和γ-环糊精。以最终用户产业为基础，分为食品、药品、化妆品及个人护理、化学品、纺织品等。按地区划分，我们研究了北美、欧洲、亚太地区和拉丁美洲地区 (LAMEA) 的市场。

相关人员的主要利益

  • 本报告定量分析了 2022 年至 2032 年环糊精市场分析的细分市场、当前趋势、估计/趋势和动态，以确定有前景的环糊精市场机会。
  • 我们提供市场研究以及与市场驱动因素、市场限制和市场机会相关的资讯。
  • 波特的五力分析揭示了买家和供应商的潜力，帮助相关人员做出利润驱动的业务决策并加强供应商和买家网路。
  • 环糊精市场细分的详细分析将有助于确定市场机会。
  • 我们根据每个地区的主要国家对全球市场的收益贡献绘製了地图。
  • 市场参与者定位有助于基准化分析，并提供对市场参与者当前地位的清晰了解。
  • 该报告包括对区域和全球环糊精市场趋势、主要企业、细分市场、应用领域和市场成长策略的分析。

可以使用此报告进行客製化（需要额外费用和时间表）

  • 製造能力
  • 投资机会
  • 供应链分析与供应商利润
  • 科技趋势分析
  • 按产品/细分市场分類的公司市场区隔分析
  • 新产品开发/主要企业产品矩阵
  • 国家、区域和全球各级的患者/流行病学资料
  • 监管指引
  • 根据客户兴趣新增其他公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 公司简介的扩充列表
  • 历史市场资料
  • 导入/汇出分析/资料
  • 主要企业详细资料（Excel 格式，包括位置、联络资讯、供应商/供应商网路等）
  • 全球/区域/国家层级参与者的市场占有率分析
  • SWOT分析
  • 成交量市场规模及预测

目录

第一章简介

第 2 章执行摘要

第三章市场概况

  • 市场定义和范围
  • 主要发现
    • 影响因素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 价值链分析
  • 价格分析
  • 关键监管分析
  • 专利形势

第四章环糊精市场：依类型

  • 概述
  • α-环糊精
  • β-环糊精
  • γ-环糊精

第五章环糊精市场：依最终用户产业

  • 概述
  • 食品
  • 药品
  • 化妆品和个人护理
  • 化学
  • 纤维
  • 其他的

第六章环糊精市场：依地区

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 其他的
  • 拉丁美洲/中东/非洲
    • 巴西
    • 沙乌地阿拉伯
    • 南非
    • 其他的

第七章 竞争形势

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 2022年主要企业定位

第八章 公司简介

  • Cayman Chemical Company
  • Cambrex Corporation
  • Wellona Pharma Private Limited.
  • Wacker Chemie AG.
  • Cyclolab
  • Tocopharm Co. Limited
  • Roquette Freres
  • Midas Pharma GmbH
  • Ligand Pharmaceuticals Incorporated
  • Cyclo Therapeutics, Inc
Product Code: A107969

The global cyclodextrin market was valued at $334.0 million in 2022 and is estimated to reach $579.6 million by 2032, exhibiting a CAGR of 5.7% from 2023 to 2032.

Cyclodextrin Market - IMG1

Cyclodextrins are cyclic oligosaccharides composed of glucose units linked by alpha-1,4-glycosidic bonds. These molecules have a unique torus or truncated cone structure, characterized by a hydrophobic central cavity and a hydrophilic outer surface. Cyclodextrins are known for their ability to form inclusion complexes with other molecules, where the guest molecule can be encapsulated within their central cavity. This property makes cyclodextrins useful in various industries, including pharmaceuticals, food, cosmetics, and more, for applications such as improving the solubility, stability, and bioavailability of different compounds.

The growing emphasis on sustainability and green chemistry practices is another driving force for the cyclodextrin market. Cyclodextrins are biodegradable and environmentally friendly, making them attractive for applications where eco-friendly alternatives are prioritized. The use of cyclodextrins in place of traditional chemicals aligns with the global push towards sustainable practices, appealing to industries seeking environmentally conscious solutions.

Moreover, ongoing research and development activities in various industries contribute to the expansion of the cyclodextrin market. Researchers are exploring new applications and formulations that leverage the unique properties of cyclodextrins. This includes novel drug delivery systems, improved encapsulation techniques, and innovative uses in areas such as agriculture and textiles. The continuous discovery of novel applications and the development of proprietary formulations drive the demand for cyclodextrins.

However, regulatory considerations also impact the cyclodextrin market. As cyclodextrins are used in various applications, including pharmaceuticals and food products, adherence to stringent regulatory requirements is crucial. Obtaining regulatory approvals for cyclodextrin-containing products can be time-consuming and expensive. Additionally, evolving regulatory landscapes and changes in compliance standards may require continuous adaptation by manufacturers, adding a layer of complexity to the market.

On the contrary, in the food and beverage sector, cyclodextrins find applications as encapsulating agents, flavor modifiers, and stabilizers. They contribute to improved product quality, taste, and shelf life. As consumers increasingly seek healthier and more natural ingredients, cyclodextrins, with their ability to mask undesirable flavors and odors, become invaluable for food manufacturers. The trend towards clean-label products and the demand for functional foods further drive the opportunities in this market segment.

The cyclodextrin market is segmented on the basis of type, end-user industry, and region. On the basis of type, the market is categorized into alpha-cyclodextrin, beta-cyclodextrin, and gamma-cyclodextrin. On the basis of end-user industry, it is divided into food, pharmaceutical, cosmetics & personal care, chemical, textile, and others. Region-wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

The global cyclodextrin market profiles leading players that include Cambrex Corporation, Cayman Chemical, Wellona Pharma, Wacker Chemie AG, Cyclolab, Tocopharm Co. Limited, Roquette Freres, Midas Pharma GmbH, Ligand Pharmaceuticals Incorporated, and Cyclo Therapeutics, Inc.

Other key players involved in the manufacturing of cyclodextrin includes Zibo Qianhui biological technology co., ltd, Xi'an Deli Biochemical Industry Co., Ltd, Merck KgaA, Otto Chemie Pvt. Ltd., VIO CHEMICALS, Ashland, and TCI Chemicals Pvt. Ltd. The global cyclodextrin market report provides in-depth competitive analysis as well as profiles of these major players.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cyclodextrin market analysis from 2022 to 2032 to identify the prevailing cyclodextrin market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the cyclodextrin market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global cyclodextrin market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Manufacturing Capacity
  • Investment Opportunities
  • Supply Chain Analysis & Vendor Margins
  • Technology Trend Analysis
  • Market share analysis of players by products/segments
  • New Product Development/ Product Matrix of Key Players
  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Import Export Analysis/Data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)
  • Market share analysis of players at global/region/country level
  • SWOT Analysis
  • Volume Market Size and Forecast

Key Market Segments

By Type

  • Alpha-Cyclodextrin
  • Beta-Cyclodextrin
  • Gamma-Cyclodextrin

By End-User Industry

  • Food
  • Pharmaceutical
  • Cosmetics and Personal Care
  • Chemical
  • Textile
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Cayman Chemical Company
    • Cambrex Corporation
    • Wellona Pharma Private Limited.
    • Wacker Chemie AG.
    • Cyclolab
    • Tocopharm Co. Limited
    • Roquette Freres
    • Midas Pharma GmbH
    • Ligand Pharmaceuticals Incorporated
    • Cyclo Therapeutics, Inc

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. Value Chain Analysis
  • 3.6. Pricing Analysis
  • 3.7. Key Regulation Analysis
  • 3.8. Patent Landscape

CHAPTER 4: CYCLODEXTRIN MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Alpha-Cyclodextrin
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Beta-Cyclodextrin
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Gamma-Cyclodextrin
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: CYCLODEXTRIN MARKET, BY END-USER INDUSTRY

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Food
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Pharmaceutical
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Cosmetics and Personal Care
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Chemical
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country
  • 5.6. Textile
    • 5.6.1. Key market trends, growth factors and opportunities
    • 5.6.2. Market size and forecast, by region
    • 5.6.3. Market share analysis by country
  • 5.7. Others
    • 5.7.1. Key market trends, growth factors and opportunities
    • 5.7.2. Market size and forecast, by region
    • 5.7.3. Market share analysis by country

CHAPTER 6: CYCLODEXTRIN MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by Type
    • 6.2.3. Market size and forecast, by End-User Industry
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Market size and forecast, by Type
      • 6.2.4.1.2. Market size and forecast, by End-User Industry
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Market size and forecast, by Type
      • 6.2.4.2.2. Market size and forecast, by End-User Industry
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Market size and forecast, by Type
      • 6.2.4.3.2. Market size and forecast, by End-User Industry
  • 6.3. Europe
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by Type
    • 6.3.3. Market size and forecast, by End-User Industry
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. Germany
      • 6.3.4.1.1. Market size and forecast, by Type
      • 6.3.4.1.2. Market size and forecast, by End-User Industry
      • 6.3.4.2. UK
      • 6.3.4.2.1. Market size and forecast, by Type
      • 6.3.4.2.2. Market size and forecast, by End-User Industry
      • 6.3.4.3. France
      • 6.3.4.3.1. Market size and forecast, by Type
      • 6.3.4.3.2. Market size and forecast, by End-User Industry
      • 6.3.4.4. Spain
      • 6.3.4.4.1. Market size and forecast, by Type
      • 6.3.4.4.2. Market size and forecast, by End-User Industry
      • 6.3.4.5. Italy
      • 6.3.4.5.1. Market size and forecast, by Type
      • 6.3.4.5.2. Market size and forecast, by End-User Industry
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Market size and forecast, by Type
      • 6.3.4.6.2. Market size and forecast, by End-User Industry
  • 6.4. Asia-Pacific
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by Type
    • 6.4.3. Market size and forecast, by End-User Industry
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. China
      • 6.4.4.1.1. Market size and forecast, by Type
      • 6.4.4.1.2. Market size and forecast, by End-User Industry
      • 6.4.4.2. India
      • 6.4.4.2.1. Market size and forecast, by Type
      • 6.4.4.2.2. Market size and forecast, by End-User Industry
      • 6.4.4.3. Japan
      • 6.4.4.3.1. Market size and forecast, by Type
      • 6.4.4.3.2. Market size and forecast, by End-User Industry
      • 6.4.4.4. South Korea
      • 6.4.4.4.1. Market size and forecast, by Type
      • 6.4.4.4.2. Market size and forecast, by End-User Industry
      • 6.4.4.5. Australia
      • 6.4.4.5.1. Market size and forecast, by Type
      • 6.4.4.5.2. Market size and forecast, by End-User Industry
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Market size and forecast, by Type
      • 6.4.4.6.2. Market size and forecast, by End-User Industry
  • 6.5. LAMEA
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by Type
    • 6.5.3. Market size and forecast, by End-User Industry
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Market size and forecast, by Type
      • 6.5.4.1.2. Market size and forecast, by End-User Industry
      • 6.5.4.2. Saudi Arabia
      • 6.5.4.2.1. Market size and forecast, by Type
      • 6.5.4.2.2. Market size and forecast, by End-User Industry
      • 6.5.4.3. South Africa
      • 6.5.4.3.1. Market size and forecast, by Type
      • 6.5.4.3.2. Market size and forecast, by End-User Industry
      • 6.5.4.4. Rest of LAMEA
      • 6.5.4.4.1. Market size and forecast, by Type
      • 6.5.4.4.2. Market size and forecast, by End-User Industry

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product mapping of top 10 player
  • 7.4. Competitive dashboard
  • 7.5. Competitive heatmap
  • 7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

  • 8.1. Cayman Chemical Company
    • 8.1.1. Company overview
    • 8.1.2. Key executives
    • 8.1.3. Company snapshot
    • 8.1.4. Operating business segments
    • 8.1.5. Product portfolio
    • 8.1.6. Business performance
    • 8.1.7. Key strategic moves and developments
  • 8.2. Cambrex Corporation
    • 8.2.1. Company overview
    • 8.2.2. Key executives
    • 8.2.3. Company snapshot
    • 8.2.4. Operating business segments
    • 8.2.5. Product portfolio
    • 8.2.6. Business performance
    • 8.2.7. Key strategic moves and developments
  • 8.3. Wellona Pharma Private Limited.
    • 8.3.1. Company overview
    • 8.3.2. Key executives
    • 8.3.3. Company snapshot
    • 8.3.4. Operating business segments
    • 8.3.5. Product portfolio
    • 8.3.6. Business performance
    • 8.3.7. Key strategic moves and developments
  • 8.4. Wacker Chemie AG.
    • 8.4.1. Company overview
    • 8.4.2. Key executives
    • 8.4.3. Company snapshot
    • 8.4.4. Operating business segments
    • 8.4.5. Product portfolio
    • 8.4.6. Business performance
    • 8.4.7. Key strategic moves and developments
  • 8.5. Cyclolab
    • 8.5.1. Company overview
    • 8.5.2. Key executives
    • 8.5.3. Company snapshot
    • 8.5.4. Operating business segments
    • 8.5.5. Product portfolio
    • 8.5.6. Business performance
    • 8.5.7. Key strategic moves and developments
  • 8.6. Tocopharm Co. Limited
    • 8.6.1. Company overview
    • 8.6.2. Key executives
    • 8.6.3. Company snapshot
    • 8.6.4. Operating business segments
    • 8.6.5. Product portfolio
    • 8.6.6. Business performance
    • 8.6.7. Key strategic moves and developments
  • 8.7. Roquette Freres
    • 8.7.1. Company overview
    • 8.7.2. Key executives
    • 8.7.3. Company snapshot
    • 8.7.4. Operating business segments
    • 8.7.5. Product portfolio
    • 8.7.6. Business performance
    • 8.7.7. Key strategic moves and developments
  • 8.8. Midas Pharma GmbH
    • 8.8.1. Company overview
    • 8.8.2. Key executives
    • 8.8.3. Company snapshot
    • 8.8.4. Operating business segments
    • 8.8.5. Product portfolio
    • 8.8.6. Business performance
    • 8.8.7. Key strategic moves and developments
  • 8.9. Ligand Pharmaceuticals Incorporated
    • 8.9.1. Company overview
    • 8.9.2. Key executives
    • 8.9.3. Company snapshot
    • 8.9.4. Operating business segments
    • 8.9.5. Product portfolio
    • 8.9.6. Business performance
    • 8.9.7. Key strategic moves and developments
  • 8.10. Cyclo Therapeutics, Inc
    • 8.10.1. Company overview
    • 8.10.2. Key executives
    • 8.10.3. Company snapshot
    • 8.10.4. Operating business segments
    • 8.10.5. Product portfolio
    • 8.10.6. Business performance
    • 8.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 02. GLOBAL CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 03. CYCLODEXTRIN MARKET FOR ALPHA-CYCLODEXTRIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. CYCLODEXTRIN MARKET FOR ALPHA-CYCLODEXTRIN, BY REGION, 2022-2032 (TONS)
  • TABLE 05. CYCLODEXTRIN MARKET FOR BETA-CYCLODEXTRIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. CYCLODEXTRIN MARKET FOR BETA-CYCLODEXTRIN, BY REGION, 2022-2032 (TONS)
  • TABLE 07. CYCLODEXTRIN MARKET FOR GAMMA-CYCLODEXTRIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. CYCLODEXTRIN MARKET FOR GAMMA-CYCLODEXTRIN, BY REGION, 2022-2032 (TONS)
  • TABLE 09. GLOBAL CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 11. CYCLODEXTRIN MARKET FOR FOOD, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. CYCLODEXTRIN MARKET FOR FOOD, BY REGION, 2022-2032 (TONS)
  • TABLE 13. CYCLODEXTRIN MARKET FOR PHARMACEUTICAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. CYCLODEXTRIN MARKET FOR PHARMACEUTICAL, BY REGION, 2022-2032 (TONS)
  • TABLE 15. CYCLODEXTRIN MARKET FOR COSMETICS AND PERSONAL CARE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. CYCLODEXTRIN MARKET FOR COSMETICS AND PERSONAL CARE, BY REGION, 2022-2032 (TONS)
  • TABLE 17. CYCLODEXTRIN MARKET FOR CHEMICAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. CYCLODEXTRIN MARKET FOR CHEMICAL, BY REGION, 2022-2032 (TONS)
  • TABLE 19. CYCLODEXTRIN MARKET FOR TEXTILE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. CYCLODEXTRIN MARKET FOR TEXTILE, BY REGION, 2022-2032 (TONS)
  • TABLE 21. CYCLODEXTRIN MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. CYCLODEXTRIN MARKET FOR OTHERS, BY REGION, 2022-2032 (TONS)
  • TABLE 23. CYCLODEXTRIN MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 24. CYCLODEXTRIN MARKET, BY REGION, 2022-2032 (TONS)
  • TABLE 25. NORTH AMERICA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 26. NORTH AMERICA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 27. NORTH AMERICA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 28. NORTH AMERICA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 29. NORTH AMERICA CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 30. NORTH AMERICA CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 (TONS)
  • TABLE 31. U.S. CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 32. U.S. CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 33. U.S. CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 34. U.S. CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 35. CANADA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 36. CANADA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 37. CANADA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 38. CANADA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 39. MEXICO CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 40. MEXICO CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 41. MEXICO CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 42. MEXICO CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 43. EUROPE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 44. EUROPE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 45. EUROPE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 46. EUROPE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 47. EUROPE CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 48. EUROPE CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 (TONS)
  • TABLE 49. GERMANY CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 50. GERMANY CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 51. GERMANY CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 52. GERMANY CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 53. UK CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 54. UK CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 55. UK CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 56. UK CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 57. FRANCE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 58. FRANCE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 59. FRANCE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 60. FRANCE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 61. SPAIN CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 62. SPAIN CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 63. SPAIN CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 64. SPAIN CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 65. ITALY CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 66. ITALY CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 67. ITALY CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 68. ITALY CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 69. REST OF EUROPE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 70. REST OF EUROPE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 71. REST OF EUROPE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 72. REST OF EUROPE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 73. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 74. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 75. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 76. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 77. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 78. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 (TONS)
  • TABLE 79. CHINA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 80. CHINA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 81. CHINA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 82. CHINA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 83. INDIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 84. INDIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 85. INDIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 86. INDIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 87. JAPAN CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 88. JAPAN CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 89. JAPAN CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 90. JAPAN CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 91. SOUTH KOREA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 92. SOUTH KOREA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 93. SOUTH KOREA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 94. SOUTH KOREA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 95. AUSTRALIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 96. AUSTRALIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 97. AUSTRALIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 98. AUSTRALIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 99. REST OF ASIA-PACIFIC CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 100. REST OF ASIA-PACIFIC CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 101. REST OF ASIA-PACIFIC CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 102. REST OF ASIA-PACIFIC CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 103. LAMEA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 104. LAMEA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 105. LAMEA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 106. LAMEA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 107. LAMEA CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 108. LAMEA CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 (TONS)
  • TABLE 109. BRAZIL CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 110. BRAZIL CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 111. BRAZIL CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 112. BRAZIL CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 113. SAUDI ARABIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 114. SAUDI ARABIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 115. SAUDI ARABIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 116. SAUDI ARABIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 117. SOUTH AFRICA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 118. SOUTH AFRICA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 119. SOUTH AFRICA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 120. SOUTH AFRICA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 121. REST OF LAMEA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 122. REST OF LAMEA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 123. REST OF LAMEA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 124. REST OF LAMEA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 125. CAYMAN CHEMICAL COMPANY: KEY EXECUTIVES
  • TABLE 126. CAYMAN CHEMICAL COMPANY: COMPANY SNAPSHOT
  • TABLE 127. CAYMAN CHEMICAL COMPANY: PRODUCT SEGMENTS
  • TABLE 128. CAYMAN CHEMICAL COMPANY: SERVICE SEGMENTS
  • TABLE 129. CAYMAN CHEMICAL COMPANY: PRODUCT PORTFOLIO
  • TABLE 130. CAYMAN CHEMICAL COMPANY: KEY STRATERGIES
  • TABLE 131. CAMBREX CORPORATION: KEY EXECUTIVES
  • TABLE 132. CAMBREX CORPORATION: COMPANY SNAPSHOT
  • TABLE 133. CAMBREX CORPORATION: PRODUCT SEGMENTS
  • TABLE 134. CAMBREX CORPORATION: SERVICE SEGMENTS
  • TABLE 135. CAMBREX CORPORATION: PRODUCT PORTFOLIO
  • TABLE 136. CAMBREX CORPORATION: KEY STRATERGIES
  • TABLE 137. WELLONA PHARMA PRIVATE LIMITED.: KEY EXECUTIVES
  • TABLE 138. WELLONA PHARMA PRIVATE LIMITED.: COMPANY SNAPSHOT
  • TABLE 139. WELLONA PHARMA PRIVATE LIMITED.: PRODUCT SEGMENTS
  • TABLE 140. WELLONA PHARMA PRIVATE LIMITED.: SERVICE SEGMENTS
  • TABLE 141. WELLONA PHARMA PRIVATE LIMITED.: PRODUCT PORTFOLIO
  • TABLE 142. WELLONA PHARMA PRIVATE LIMITED.: KEY STRATERGIES
  • TABLE 143. WACKER CHEMIE AG.: KEY EXECUTIVES
  • TABLE 144. WACKER CHEMIE AG.: COMPANY SNAPSHOT
  • TABLE 145. WACKER CHEMIE AG.: PRODUCT SEGMENTS
  • TABLE 146. WACKER CHEMIE AG.: SERVICE SEGMENTS
  • TABLE 147. WACKER CHEMIE AG.: PRODUCT PORTFOLIO
  • TABLE 148. WACKER CHEMIE AG.: KEY STRATERGIES
  • TABLE 149. CYCLOLAB: KEY EXECUTIVES
  • TABLE 150. CYCLOLAB: COMPANY SNAPSHOT
  • TABLE 151. CYCLOLAB: PRODUCT SEGMENTS
  • TABLE 152. CYCLOLAB: SERVICE SEGMENTS
  • TABLE 153. CYCLOLAB: PRODUCT PORTFOLIO
  • TABLE 154. CYCLOLAB: KEY STRATERGIES
  • TABLE 155. TOCOPHARM CO. LIMITED: KEY EXECUTIVES
  • TABLE 156. TOCOPHARM CO. LIMITED: COMPANY SNAPSHOT
  • TABLE 157. TOCOPHARM CO. LIMITED: PRODUCT SEGMENTS
  • TABLE 158. TOCOPHARM CO. LIMITED: SERVICE SEGMENTS
  • TABLE 159. TOCOPHARM CO. LIMITED: PRODUCT PORTFOLIO
  • TABLE 160. TOCOPHARM CO. LIMITED: KEY STRATERGIES
  • TABLE 161. ROQUETTE FRERES: KEY EXECUTIVES
  • TABLE 162. ROQUETTE FRERES: COMPANY SNAPSHOT
  • TABLE 163. ROQUETTE FRERES: PRODUCT SEGMENTS
  • TABLE 164. ROQUETTE FRERES: SERVICE SEGMENTS
  • TABLE 165. ROQUETTE FRERES: PRODUCT PORTFOLIO
  • TABLE 166. ROQUETTE FRERES: KEY STRATERGIES
  • TABLE 167. MIDAS PHARMA GMBH: KEY EXECUTIVES
  • TABLE 168. MIDAS PHARMA GMBH: COMPANY SNAPSHOT
  • TABLE 169. MIDAS PHARMA GMBH: PRODUCT SEGMENTS
  • TABLE 170. MIDAS PHARMA GMBH: SERVICE SEGMENTS
  • TABLE 171. MIDAS PHARMA GMBH: PRODUCT PORTFOLIO
  • TABLE 172. MIDAS PHARMA GMBH: KEY STRATERGIES
  • TABLE 173. LIGAND PHARMACEUTICALS INCORPORATED: KEY EXECUTIVES
  • TABLE 174. LIGAND PHARMACEUTICALS INCORPORATED: COMPANY SNAPSHOT
  • TABLE 175. LIGAND PHARMACEUTICALS INCORPORATED: PRODUCT SEGMENTS
  • TABLE 176. LIGAND PHARMACEUTICALS INCORPORATED: SERVICE SEGMENTS
  • TABLE 177. LIGAND PHARMACEUTICALS INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 178. LIGAND PHARMACEUTICALS INCORPORATED: KEY STRATERGIES
  • TABLE 179. CYCLO THERAPEUTICS, INC: KEY EXECUTIVES
  • TABLE 180. CYCLO THERAPEUTICS, INC: COMPANY SNAPSHOT
  • TABLE 181. CYCLO THERAPEUTICS, INC: PRODUCT SEGMENTS
  • TABLE 182. CYCLO THERAPEUTICS, INC: SERVICE SEGMENTS
  • TABLE 183. CYCLO THERAPEUTICS, INC: PRODUCT PORTFOLIO
  • TABLE 184. CYCLO THERAPEUTICS, INC: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. CYCLODEXTRIN MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF CYCLODEXTRIN MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN CYCLODEXTRIN MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN CYCLODEXTRIN MARKET (2023-2032)
  • FIGURE 05. BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. BARGAINING POWER OF BUYERS
  • FIGURE 07. THREAT OF SUBSTITUTION
  • FIGURE 08. THREAT OF SUBSTITUTION
  • FIGURE 09. COMPETITIVE RIVALRY
  • FIGURE 10. GLOBAL CYCLODEXTRIN MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. PRICING ANALYSIS: CYCLODEXTRIN MARKET 2022 AND 2032
  • FIGURE 12. IMPACT OF KEY REGULATION: CYCLODEXTRIN MARKET
  • FIGURE 13. PATENT ANALYSIS BY COMPANY
  • FIGURE 14. PATENT ANALYSIS BY COUNTRY
  • FIGURE 15. CYCLODEXTRIN MARKET, BY TYPE, 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR ALPHA-CYCLODEXTRIN, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR BETA-CYCLODEXTRIN, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR GAMMA-CYCLODEXTRIN, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR FOOD, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR PHARMACEUTICAL, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR COSMETICS AND PERSONAL CARE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR CHEMICAL, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR TEXTILE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 26. CYCLODEXTRIN MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 27. U.S. CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. CANADA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. MEXICO CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. GERMANY CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. UK CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. FRANCE CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. SPAIN CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. ITALY CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. REST OF EUROPE CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. CHINA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. INDIA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. JAPAN CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. SOUTH KOREA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. AUSTRALIA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. REST OF ASIA-PACIFIC CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. BRAZIL CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. SAUDI ARABIA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. SOUTH AFRICA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. REST OF LAMEA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 49. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 50. COMPETITIVE DASHBOARD
  • FIGURE 51. COMPETITIVE HEATMAP: CYCLODEXTRIN MARKET
  • FIGURE 52. TOP PLAYER POSITIONING, 2022